Foreign Filer Report • Dec 8, 2016
Preview not available for this file type.
Download Source File6-K 1 dp70994_6k.htm FORM 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December , 2016
Commission File Number: 001-13742
ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)
Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes No X
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes No X
ISRAEL CHEMICALS LTD.
INCORPORATION BY REFERENCE
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the exte nt not superseded by documents or reports subsequently filed or furnished.
ISRAEL CHEMICALS LTD.
Item 1
Withdrawal of Appeal over Tax Assessment
Further to the Company's immediate report dated December 31, 2013, and to Note 20D of the Company's annual financial statements for 2015, regarding an assessment by the Israeli Tax Authority, the Company hereby reports that it withdrew the appeal filed on February 2015 in respect of the aforementi oned tax assessment. The additional tax for payment, in excess of the amounts already paid by the Company to date, is NIS 228 million (about $60 million), including interest and linkage as of the date of this report. Accordingly, the Company is expected to update the provisions booked in its financial statements for the fourth quarter and for 2016 in the amount of about NIS 130 million (about $34 million).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| /s/ Kobi Altman | |
|---|---|
| Name: | Kobi Altman |
| Title: | Chief Financial Officer |
| /s/ Lisa Haimovitz | |
|---|---|
| Name: | Lisa Haimovitz |
| Title: | Senior Vice President, Global General Counsel and Corporate Secretary |
Date: December 8 , 2016
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.